Cargando…
Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
Considerable attention has been focused on long‐term use of proton pump inhibitor (PPI) medications in relation to increased risk of cancer via stimulation of DNA‐damaged cells. The aim of this study is to examine the dose‐dependent effect of PPI on periampullary cancers in a national population‐bas...
Autores principales: | Chien, Li‐Nien, Huang, Yan‐Jiun, Shao, Yu‐Hsuan Joni, Chang, Chen‐Jung, Chuang, Ming‐Tsang, Chiou, Hung‐Yi, Yen, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738410/ https://www.ncbi.nlm.nih.gov/pubmed/26488896 http://dx.doi.org/10.1002/ijc.29896 |
Ejemplares similares
-
Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012) -
Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study
por: Ikuta, Keiko, et al.
Publicado: (2021) -
Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study
por: Huang, Yan-Jiun, et al.
Publicado: (2016) -
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
por: Poulsen, A H, et al.
Publicado: (2009) -
Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)